Macular Chats are a series of free, informative audio conversations hosted by Macular Degeneration Research, a BrightFocus Foundation program, featuring retina specialists and other eye care experts who will discuss various aspects of living with macular degeneration and geographic atrophy.
Topics will include macular degeneration treatments, remaining independent, and promising research on the horizon.
#Ophthalmology #Macular #MacularDegeneration #GeographicAtrophy #VisionLoss #LowVision
All content for Macular Chats is the property of BrightFocus Foundation and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Macular Chats are a series of free, informative audio conversations hosted by Macular Degeneration Research, a BrightFocus Foundation program, featuring retina specialists and other eye care experts who will discuss various aspects of living with macular degeneration and geographic atrophy.
Topics will include macular degeneration treatments, remaining independent, and promising research on the horizon.
#Ophthalmology #Macular #MacularDegeneration #GeographicAtrophy #VisionLoss #LowVision
Ever wonder how Macular Degeneration Research identifies and supports the most promising scientific studies around the world? We recently awarded $3.8 million to researchers advancing bold ideas to better understand, prevent, and treat macular degeneration. In this episode of Macular Chats, Dr. Diane Bovenkamp highlights several of this year’s groundbreaking projects and explain how they’re driving progress in early detection, risk reduction, new treatments—and ultimately, a cure.
Macular Chats
Macular Chats are a series of free, informative audio conversations hosted by Macular Degeneration Research, a BrightFocus Foundation program, featuring retina specialists and other eye care experts who will discuss various aspects of living with macular degeneration and geographic atrophy.
Topics will include macular degeneration treatments, remaining independent, and promising research on the horizon.
#Ophthalmology #Macular #MacularDegeneration #GeographicAtrophy #VisionLoss #LowVision
